Extraskeletal activity of vitamin D and a potential association with diabetes mellitus

Tamara Dragović; Slavica Rađen; Branka Djurović; Violeta Rabrenović

doi:10.2298/VSP151011114D

Tamara Dragović Clinic of Endocrinology, Military Medical Academy, Belgrade, Serbia; Faculty of Medicine of the Military Medical Academy, University of Defence, Belgrade, Serbia
Slavica Rađen Faculty of Medicine of the Military Medical Academy, University of Defence, Belgrade, Serbia; Institute of Hygiene, Military Medical Academy, Belgrade,Serbia.
Branka Djurović Faculty of Medicine of the Military Medical Academy, University of Defence, Belgrade, Serbia; Institute of Occupational Medicine, Military Medical Academy, Belgrade, Serbia
Violeta Rabrenović Faculty of Medicine of the Military Medical Academy, University of Defence, Belgrade, Serbia; Clinic of Nephrology, Military Medical Academy, Belgrade, Serbia.

DOI: https://doi.org/10.2298/VSP151011114D

Keywords: diabetes mellitus, vitamin D, vitamin D deficiency, risk assessment, dietary supplements,

References

Guo J, Liu Z. Multiple effects of vitamin D. Chin Med J 2013; 126(15): 2978−83.

Alaverz J, Ashraf A. Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010; 2010: 351385.

Li J, Xiao B, Xiang Y. Immune function of vitamin D in type 1 diabetes mellitus. IJBM 2014; 4(2): 67−71.

Mathieu C, Badenhoop K. Vitamin D and type 1 diabetes mellitus: State of the art. Trends Endocrinol Metab 2005; 16(6): 261−6.

Valdivielso JM, Fernandez E. Vitamin D receptor polymorphisms and diseases. Clin Chim Acta 2006; 371(1−2): 1−12.

Henry HL. Regulation of vitamin D metabolism. Best Pract Res Clin Endocrinol Metab 2011; 25(4): 531−41.

Gillespie KM. Type 1 diabetes: Pathogenesis and prevention. CMAJ 2006; 175(2): 165−70.

Bikle DD. Vitamin D regulation of immune function. Vitam Horm 2011; 86: 1−11.

Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1α, 25-dihydroxyvitaminD3 analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2001; 51(5): 1367−74.

Casteels KM, Mathieu C, Waer M, Valckx D, Overbergh L, Laureys JM, et al. Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induc-tion course of cyclosporin A. Endocrinology 1998; 139(1): 95−102.

Gabbay MA, Sato MN, Finazzo C, Duarte AJ, Dib SA. Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual β-cell function in new-onset type 1 diabetes mellitus. Arch Pediatr Adolesc Med 2012; 166(7): 601−7.

Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. The EURODIAB Subs-tudy 2 Study Group. Diabetologia 1999; 42(1): 51−4.

Stene LC, Joner G. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 di-abetes: A large, population-based, case-control study. Am J Clin Nutr 2003; 78(6): 1128−34.

Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM. In-take of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet 2001; 358(9292): 1500−3.

Visalli N, Sebastiani L, Adorisio E, Conte A, De Cicco A, D'Elia R, et al. Environmental risk factors for type 1 diabetes in Rome and province. Arch Dis Child 2003; 88(8): 695−8.

Simpson M, Brady H, Yin X, Seifert J, Barriga K, Hoffman M, et al. No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: The Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia 2011; 54(11): 2779−88.

Brekke HK, Ludvigsson J. Vitamin D supplementation and di-abetes-related autoimmunity in the ABIS study. Pediatr Di-abetes 2007; 8(1): 11−4.

Fronczak CM, Barón AE, Chase PH, Ross C, Brady HL, Hoffman M, et al. In utero dietary exposures and risk of islet autoim-munity in children. Diabetes Care 2003; 26(12): 3237−42.

Stene LC, Ulriksen J, Magnus P, Joner G. Use of cod liver oil dur-ing pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologia 2000; 43(9): 1093−8.

Marjamäki L, Niinistö S, Kenward MG, Uusitalo L, Uusitalo U, Ovaskainen ML, et al. Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring. Diabetologia 2010; 53(8): 1599−607.

Miettinen ME, Reinert L, Kinnunen L, Harjutsalo V, Koskela P, Surcel HM, et al. Serum 25-hydroxyvitamin D level during early pregnancy and type 1 diabetes risk in the offspring. Diabetologia 2012; 55(5): 1291−4.

Matsuda S, Kitagishi Y. Peroxisome proliferator-activated recep-tor and vitamin D receptor signaling pathways in cancer cells. Cancer 2013; 5(4): 1261−70.

Bourlon PM, Billaudel B, Faure-Dussert A. Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J Endocrinol 1999; 160(1): 87−95.

Maestro B, Dávila N, Carranza CM, Calle C. Identification of a Vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 2003; 84(2−3): 223−30.

Moreira T, Hamadeh M. The role od vitamin D deficiency in the pathogenesis of type 2 diabetes. E Spen Eur E J Clin Nutr Metab 2010; 5(4): e155−65.

Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Rheum Dis Clin North Am 2012; 38(1): 179−206.

Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is asso-ciated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79(5): 820−5.

Dutta D, Maisnam I, Shrivastava A, Sinha A, Ghosh S, Mukhopad-hyay P, et al. Serum vitamin-D predicts insulin resistance in in-dividuals with prediabetes. Indian J Med Res 2013; 138(6): 853−60.

Baynes KC, Boucher BJ, Feskens EJ, Kromhout D. Vitamin D, glu-cose tolerance and insulinaemia in elderly men. Diabetologia 1997; 40(3): 344−7.

Hyppönen E, Power C. Vitamin D status and glucose homeosta-sis in the 1958 British birth cohort: The role of obesity. Di-abetes Care 2006; 29(10): 2244−6.

Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 2009; 32(7): 1278−83.

Chonchol M, Scragg R. 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutri-tion Examination Survey. Kidney Int 2007; 71(2): 134−9.

Sheth J, Shah A, Sheth F, Trivedi S, Lele M, Shah M, et al. Does vitamin D play a significant role in type 2 diabetes. BMC En-docr Disord 2015; 15: 5.

Manco M, Calvani M, Nanni G, Greco AV, Iaconelli A, Gasbarrini G, et al. Low 25-hydroxyvitamin D does not affect insulin sensitivity in obesity after bariatric surgery. Obes Res 2005; 13(10): 1692−700.

Alemzadeh R, Kichler J, Babar G, Calhoun M. Hypovitaminosis D in obese children and adolescents: Relationship with adiposity, insulin sensitivity, ethnicity, and season. Metab Clin Exp 2008; 57(2): 183−91.

McGill A, Stewart JM, Lithander FE, Strik CM, Poppitt SD. Rela-tionships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in over-weight and obesity. Nutr J 2008; 7: 4.

Talaei A, Mohamadi M, Adgi Z. The effect of vitamin D on in-sulin resistance in patients with type 2 diabetes. Diabetol Me-tabol Syndr 2013; 5: 8.

von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr 2010; 103(4): 549−55.

Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007; 30(4): 980–6.

Grimnes G, Figenschau Y, Almås B, Jorde R. Vitamin D, insulin secretion, sensitivity, and lipids: Results from a case-control study and a randomized controlled trial using hyperglycemic clamp technique. Diabetes 2011; 60(11): 2748−57.

Jorde R, Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr 2009; 48(6): 349−54.

Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 2009; 26(1): 19−27.

Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: The Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008; 57(10): 2619−25.

Mattila C, Knekt P, Männistö S, Rissanen H, Laaksonen MA, Montonen J, et al. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 2007; 30(10): 2569−70.

Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: A meta-analysis of prospective studies. Diabetes Care 2013; 36(5): 1422−8.

Zoppini G, Galletti A, Targher G, Brangani C, Pichiri I, Trombetta M, et al. Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in pa-tients with type 2 diabetes. BMJ Open Diab Res Care 2015; 3(1): e000058.

Svoren BM, Volkening LK, Wood JR, Laffel LM. Significant vita-min D deficiency in youth with type 1 diabetes mellitus. J Pe-diatr 2009; 154(1): 132−4.

Joergensen C, Gall M, Schmedes A, Tarnow L, Parving H, Rossing P. Vitamin D levels and mortality in type 2 diabetes. Diabetes Care 2010; 33(10): 2238−43.

Joergensen C, Hovind P, Schmedes A, Parving H, Rossing P. Vitamin D levels, microvascular complications, and mortality in type 1 diabetes. Diabetes Care 2011; 34(5): 1081−5.

Jennersjo P, Guldbrand H, Bjorne S, Lanne T, Fredrikson M, Lindstrom T, et al. A prospective observational study of all-cause mortality in relation to serum 25-OH vitamin D 3 and parathyroid hormone levels in patients with type 2 diabetes. Diabetol Metab Syndr 2015; 7: 53.

Kaur H, Donaghue KC, Chan AK, Benitez-Aguirre P, Hing S, Lloyd M, et al. Vitamin D deficiency is associated with retinopathy in children and adolescents with type 1 diabetes. Diabetes Care 2011; 34(6): 1400−2.

Ahmadieh H, Azar S, Lakkis N, Arabi A. Hypovitaminosis D in patients with type 2 diabetes mellitus: A relation to disease control and complications. ISRN Endocrinol 2013; 2013: 641098.

He R, Shen J, Liu F, Zeng H, Li L, Yu H, et al. Vitamin D defi-ciency increases the risk of retinopathy in Chinese patients with type 2 diabetes. Diabet Med 2014; 31(12): 1657−64.

Usluogullar CA, Balkan F, Caner S, Ucler R, Kaya C, Ersoy R, et al. The relationship between microvascular complications and vitamin D deficiency in tyšpe 2 diabetes mellitus. BMC Endocr Disord 2015; 15: 33.

Lv WS, Zhao WJ, Gong SL, Fang DD, Wang B, Fu ZJ, et al. Se-rum 25-hydroxyvitamin D levels and peripheral neuropathy in patients with type 2 diabetes: A systematic review and meta-analysis. J Endocrinol Invest 2015; 38(5): 513−8.

Maser RE, Lenhard JM, Pohlig RT. Vitamin D Insufficiency is Associated with Reduced Parasympathetic Nerve Fiber Func-tion in Type 2 Diabetes. Endocr Pract 2015; 21(2): 174−81.

Shehab D, Al-Jarallah K, Mojiminiyi OA, Al Mohamedy H, Abdella NA. Does Vitamin D deficiency play a role in peripheral neu-ropathy in Type 2 diabetes. Diabet Med 2012; 29(1): 43−9.

Albert DM, Scheef EA, Wang S, Mehraein F, Darjatmoko SR, So-renson CM, et al. Calcitriol is a potent inhibitor of retinal neo-vascularization. Invest Ophthalmol Vis Sci 2007; 48(5): 2327−34.

Shokravi MT, Marcus DM, Alroy J, Egan K, Saornil MA, Albert DM. Vitamin D inhibits angiogenesis in transgenic murine re-tinoblastoma. Invest Ophtalmol Vis Sci 1995; 36(1): 83−7.

Sanchez-Niño M, Bozic M, Córdoba-Lanús E, Valcheva P, Gracia O, Ibarz M, et al. Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy. Am J Physiol Renal Physiol 2012; 302(6): F647−57.

Agarwal R. Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD. Clin J Am Soc Nephrol 2009; 4(9): 1523−8.

Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 2009; 75(1): 88−95.

Fernandez-Juarez G, Luno J, Barrio V, de Vinuesa GS, Praga M, Goicoechea M, et al. 25(OH) Vitamin D lelevs and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin sysem. Clin J Am Soc Nephrol 2013; 8(11): 1870−6.

Kim MJ, Frankel AH, Donaldson M, Darch SJ, Pusey CD, Hill PD, et al. Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition. Kidney Int 2011; 80(8): 851−60.

Bordelon P, Ghetu MV, Langan RC. Recognition and manage-ment of vitamin D deficiency. Am Fam Physician 2009; 80(8): 841−6.

Marti T, Campbel RK. Vitamin D and diabetes. Diabet Spec 2011; 24(2): 113−8.

Harris SS. Vitamin D in type 1 diabetes prevention. J Nutr 2005; 135(2): 323−5.

WHO Guideline. Vitamin and mineral requirements in human nutrition. Geneva: World Health Organisation and Food and Agriculture Organisation of the United Nations; 2004.

Institute of Medicine Food and Nutrition Board. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride. Washington, D.C: National Academy Press; 2010.

American Academy of Pediatrics. Committy on nutrition. In: Pediatric Nutrition Handbook. 6th ed. Elk Grove Village, IL: American Acadamey of Pediatrics; 2008.

Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96(7): 1911−30.

WHO. Guideline: Vitamin D supplementation in pregnant women. Geneva: World Health Organization; 2012.

Scragg R. Vitamin D and type 2 diabetes: Are we ready for a prevention trial. Diabetes 2008; 57(10): 2565−6.

National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and diseasein chronic kidney disease. Am J Kidney Dis 2003; 42(4 Suppl 3): S1−201.